April 19, 2018 / 4:11 AM / 6 months ago

BRIEF-Cadila Healthcare Says Zydus Gets Final Approval From U.S. FDA For Diclofenac Sodium Topical Solution

April 19 (Reuters) - Cadila Healthcare Ltd:

* SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR DICLOFENAC SODIUM TOPICAL SOLUTION

* SAYS IT SOLUTION TO BE MANUFACTURED AT GROUP'S TOPICAL MANUFACTURING FACILITY AT AHMEDABAD Source text - bit.ly/2HLzxSa Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below